Some of the transcription factors driving BRCA gene expression are known oncogenes (MYC) or putative oncogenes in ovarian cancer, based on functional data and evidence of genetic activation in primary HGSOC: MYC is amplified in 30% of HGSOC (6), and E2F3 is amplified in about 10% (60). Here, MYC is linked to ovarian cancer.